Kevin Hybiske
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kevin Hybiske has a total of 174 co-authors. Here are the top co-authors by number of shared publications:
Yibing Wang
University of Washington
5 shared publications- Andra Waagmeester
Micelio, Antwerp, Belgium
4 shared publications - Andrew I. Su
The Scripps Research Institute
4 shared publications - Benjamin M . Good
The Scripps Research Institute
4 shared publications - Christine M. Khosropour
Department of Epidemiology, University of Washington, Seattle, USA
4 shared publications - Chunlei Wu
The Scripps Research Institute
4 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (10)
Estimation of Antimicrobial-Resistant Mycoplasma genitalium Infections in People Aged 14–59 Years: Results From the National Health and Nutrition Examination Survey, United States, 2017–2018
Mycoplasma genitalium antimicrobial resistance is common in US sexual health clinics. Population-level prevalence is unknown. We tested National Health and Nutrition Examination Survey (2017–2018) specimens for M genitalium resistance mutations (n = 58). Macrolide resistance prevalence was 42.7% (95% CI, 24.4%–62.7%). Quinolone resistance was not detected. Macrolide resistance testing should guide azithromycin treatment.
- 29 September 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (10)
Open AccessEstimation of Antimicrobial-Resistant Mycoplasma genitalium Infections in People Aged 14–59 Years: Results From the National Health and Nutrition Examination Survey, United States, 2017–2018
Mycoplasma genitalium antimicrobial resistance is common in US sexual health clinics. Population-level prevalence is unknown. We tested National Health and Nutrition Examination Survey (2017–2018) specimens for M genitalium resistance mutations (n = 58). Macrolide resistance prevalence was 42.7% (95% CI, 24.4%–62.7%). Quinolone resistance was not detected. Macrolide resistance testing should guide azithromycin treatment.
- 23 September 2026
- Published by Springer Nature
- Vol. 3073, 211-220
Chromosome Editing Using the Lambda Red Recombinase System in Chlamydia trachomatis and Chlamydia muridarum
This chapter describes a lambda Red-based recombineering approach for targeted genetic manipulation in Chlamydia species. The method uses a non-replicative plasmid encoding lambda Red recombination proteins together with locus-specific homology arms to generate precise gene deletions in the Chlamydia chromosome. Detailed protocols are provided for construct design, host cell-based selection, and genetic validation of recombinant strains, and noteworthy considerations for transforming different Chlamydia species and strains are given.
- 23 September 2026
- Published by Springer Nature
- Vol. 3073, 211-220
Chromosome Editing Using the Lambda Red Recombinase System in Chlamydia trachomatis and Chlamydia muridarum
This chapter describes a lambda Red-based recombineering approach for targeted genetic manipulation in Chlamydia species. The method uses a non-replicative plasmid encoding lambda Red recombination proteins together with locus-specific homology arms to generate precise gene deletions in the Chlamydia chromosome. Detailed protocols are provided for construct design, host cell-based selection, and genetic validation of recombinant strains, and noteworthy considerations for transforming different Chlamydia species and strains are given.
- Open Access
- 11 August 2026
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 94 (8) , e0026626
Genome-wide association studies of C. trachomatis identify novel tissue tropism-predicting loci and sequences that discriminate among major genome sequence clades
Chlamydia trachomatis infections cause chronic and debilitating diseases of the eye and genital tract. Recent data suggest that infections are common at other tissue sites, including the lower intestinal tract of both men and women. Our previous work demonstrated tropism-predicting sequences in male rectal isolates, with modification in the PmpE sequence and predicted structure being highly correlated with male rectal infection. An expanded collection of strains from five different tissue sites was used to identify novel tropism-predicting markers for the different tissues. These data demonstrate that C. trachomatis strains colonizing the male rectum are unique with respect to all other tested sites. Additionally, ocular strains have a consistent set of genes that separate them from strains isolated from any other tissue. Novel polymorphisms predictive of ocular tropism include a single indel in mrcA and a region between pmpH and pmpI , including the hypothetical gene ct873 . These analyses also identified a novel urogenital clade, termed the variable-OmpA clade, in which strains carry a variety of ompA sequences in an otherwise shared genomic background. This clade is defined primarily by single-nucleotide polymorphisms (SNPs) within and adjacent to the highly variable plasticity zone. Collectively, this work explores the continuing evolution of C. trachomatis strains and clades in a genomic background that only engages in intraspecies horizontal gene transfer.
- 11 August 2026
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 94 (8) , e0026626
Open AccessGenome-wide association studies of C. trachomatis identify novel tissue tropism-predicting loci and sequences that discriminate among major genome sequence clades
Chlamydia trachomatis infections cause chronic and debilitating diseases of the eye and genital tract. Recent data suggest that infections are common at other tissue sites, including the lower intestinal tract of both men and women. Our previous work demonstrated tropism-predicting sequences in male rectal isolates, with modification in the PmpE sequence and predicted structure being highly correlated with male rectal infection. An expanded collection of strains from five different tissue sites was used to identify novel tropism-predicting markers for the different tissues. These data demonstrate that C. trachomatis strains colonizing the male rectum are unique with respect to all other tested sites. Additionally, ocular strains have a consistent set of genes that separate them from strains isolated from any other tissue. Novel polymorphisms predictive of ocular tropism include a single indel in mrcA and a region between pmpH and pmpI , including the hypothetical gene ct873 . These analyses also identified a novel urogenital clade, termed the variable-OmpA clade, in which strains carry a variety of ompA sequences in an otherwise shared genomic background. This clade is defined primarily by single-nucleotide polymorphisms (SNPs) within and adjacent to the highly variable plasticity zone. Collectively, this work explores the continuing evolution of C. trachomatis strains and clades in a genomic background that only engages in intraspecies horizontal gene transfer.
- 31 July 2026
- Published by Springer Nature in Nature Reviews Gastroenterology & Hepatology
- Vol. 23 (11) , 830-847
Mechanisms, management and prevention of anorectal sexually transmitted infections
- 31 July 2026
- Published by Springer Nature in Nature Reviews Gastroenterology & Hepatology
- Vol. 23 (11) , 830-847
Mechanisms, management and prevention of anorectal sexually transmitted infections
- Open Access
- 31 July 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (3) , e438-e440
Crisis as Catalyst: The Future of the NIH Driving Scientific Discovery
The National Institutes of Health (NIH) has an unparalleled record of advancing biomedical science. Today, 2 critical challenges threaten its future impact. We propose concrete steps to restore the NIH's trajectory and preserve its leadership in scientific discovery.
- 31 July 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (3) , e438-e440
Open AccessCrisis as Catalyst: The Future of the NIH Driving Scientific Discovery
The National Institutes of Health (NIH) has an unparalleled record of advancing biomedical science. Today, 2 critical challenges threaten its future impact. We propose concrete steps to restore the NIH's trajectory and preserve its leadership in scientific discovery.
- Open Access
- 14 November 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (11) , e0311630
Development of a lambda Red based system for gene deletion in Chlamydia
The ability to efficiently target loci in the Chlamydia trachomatis genome for deletion remains a desirable goal in the field and new strategies need to be developed and refined. Here we describe the development and application of a lambda red recombineering system for Chlamydia. Using a non-replicative plasmid encoding key lambda Red components and targeting sequences, we demonstrate the efficient deletion of numerous gene targets in the model chlamydial strains C. trachomatis L2/434 and C. muridarum. For initial development of the system, we targeted the incA gene of C. trachomatis for deletion. Deletion mutants containing a chloramphenicol resistance marker were recovered within 3 rounds of selection, or 2 rounds of passaging, in McCoy cells and the resulting clones (CTΔincA) were verified by PCR-based genotyping and whole genome sequencing. Phenotypic assessment of host cells infected with CTΔincA was performed by immunofluorescence microscopy and confirmed the lack of IncA expression and the uniform presence of nonfusogenic vacuoles (inclusions) across CTΔincA-infected monolayers. To explore the utility of this system, we deleted 5 additional candidate virulence factors in C. trachomatis and C. muridarum, including deletions of single and multiple genes. We expect lambda Red recombineering to offer a powerful new strategy for making gene deletion and/or replacement mutants in Chlamydia.
- 14 November 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (11) , e0311630
Open AccessDevelopment of a lambda Red based system for gene deletion in Chlamydia
The ability to efficiently target loci in the Chlamydia trachomatis genome for deletion remains a desirable goal in the field and new strategies need to be developed and refined. Here we describe the development and application of a lambda red recombineering system for Chlamydia. Using a non-replicative plasmid encoding key lambda Red components and targeting sequences, we demonstrate the efficient deletion of numerous gene targets in the model chlamydial strains C. trachomatis L2/434 and C. muridarum. For initial development of the system, we targeted the incA gene of C. trachomatis for deletion. Deletion mutants containing a chloramphenicol resistance marker were recovered within 3 rounds of selection, or 2 rounds of passaging, in McCoy cells and the resulting clones (CTΔincA) were verified by PCR-based genotyping and whole genome sequencing. Phenotypic assessment of host cells infected with CTΔincA was performed by immunofluorescence microscopy and confirmed the lack of IncA expression and the uniform presence of nonfusogenic vacuoles (inclusions) across CTΔincA-infected monolayers. To explore the utility of this system, we deleted 5 additional candidate virulence factors in C. trachomatis and C. muridarum, including deletions of single and multiple genes. We expect lambda Red recombineering to offer a powerful new strategy for making gene deletion and/or replacement mutants in Chlamydia.
- 19 April 2024
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 230 (1) , 250-262
Chlamydia trachomatis Seroassays Used in Epidemiologic Research: A Narrative Review and Practical Considerations
Chlamydia trachomatis (CT) is a sexually transmitted infection that can lead to adverse reproductive health outcomes. CT prevalence estimates are primarily derived from screening using nucleic acid amplification tests (NAATs). However, screening guidelines in the United States only include particular subpopulations, and NAATs only detect current infections. In contrast, seroassays identify past CT infections, which is important for understanding the public health impacts of CT, including pelvic inflammatory disease and tubal factor infertility. Older seroassays have been plagued by low sensitivity and specificity and have not been validated using a consistent reference measure, making it challenging to compare studies, define the epidemiology of CT, and determine the effectiveness of control programs. Newer seroassays have better performance characteristics. This narrative review summarizes the “state of the science” for CT seroassays that have been applied in epidemiologic studies and provides practical considerations for interpreting the literature and employing seroassays in future research.
- 19 April 2024
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 230 (1) , 250-262
Chlamydia trachomatis Seroassays Used in Epidemiologic Research: A Narrative Review and Practical Considerations
Chlamydia trachomatis (CT) is a sexually transmitted infection that can lead to adverse reproductive health outcomes. CT prevalence estimates are primarily derived from screening using nucleic acid amplification tests (NAATs). However, screening guidelines in the United States only include particular subpopulations, and NAATs only detect current infections. In contrast, seroassays identify past CT infections, which is important for understanding the public health impacts of CT, including pelvic inflammatory disease and tubal factor infertility. Older seroassays have been plagued by low sensitivity and specificity and have not been validated using a consistent reference measure, making it challenging to compare studies, define the epidemiology of CT, and determine the effectiveness of control programs. Newer seroassays have better performance characteristics. This narrative review summarizes the “state of the science” for CT seroassays that have been applied in epidemiologic studies and provides practical considerations for interpreting the literature and employing seroassays in future research.
- 9 April 2024
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 92 (4) , e0050323
Antibodies from chlamydia-infected individuals facilitate phagocytosis via Fc receptors
Non-neutralizing functions of antibodies, including phagocytosis, may play a role in Chlamydia trachomatis (CT) infection, but these functions have not been studied and assays are lacking. We utilized a flow-cytometry-based assay to determine whether serum samples from a well-characterized cohort of CT-infected and naïve control individuals enhanced phagocytosis via Fc-receptor-expressing THP-1 cells, and whether this activity correlated with antibody titers. Fc-receptor-mediated phagocytosis was detected only in CT+ donors. Phagocytosis generally did not correlate well with antibody titer. In addition, we found that complement from both CT+ and negative individuals enhanced phagocytosis of CT into primary neutrophils. These results suggest that anti-CT antibodies can have functions that are not reflected by titer. This method could be used to quantitively measure Fc-receptor-mediated function of anti-CT antibodies or complement activity and could reveal new immune correlates of protection.
- 9 April 2024
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 92 (4) , e0050323
Antibodies from chlamydia-infected individuals facilitate phagocytosis via Fc receptors
Non-neutralizing functions of antibodies, including phagocytosis, may play a role in Chlamydia trachomatis (CT) infection, but these functions have not been studied and assays are lacking. We utilized a flow-cytometry-based assay to determine whether serum samples from a well-characterized cohort of CT-infected and naïve control individuals enhanced phagocytosis via Fc-receptor-expressing THP-1 cells, and whether this activity correlated with antibody titers. Fc-receptor-mediated phagocytosis was detected only in CT+ donors. Phagocytosis generally did not correlate well with antibody titer. In addition, we found that complement from both CT+ and negative individuals enhanced phagocytosis of CT into primary neutrophils. These results suggest that anti-CT antibodies can have functions that are not reflected by titer. This method could be used to quantitively measure Fc-receptor-mediated function of anti-CT antibodies or complement activity and could reveal new immune correlates of protection.
- 17 November 2022
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 90 (11) , e0026522
Genomic Analysis of MSM Rectal Chlamydia trachomatis Isolates Identifies Predicted Tissue-Tropic Lineages Generated by Intraspecies Lateral Gene Transfer-Mediated Evolution
Chlamydia trachomatis is an obligate intracellular bacterium that causes serious diseases in humans. Rectal infection and disease caused by this pathogen are important yet understudied aspects of C. trachomatis natural history.
- 17 November 2022
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 90 (11) , e0026522
Genomic Analysis of MSM Rectal Chlamydia trachomatis Isolates Identifies Predicted Tissue-Tropic Lineages Generated by Intraspecies Lateral Gene Transfer-Mediated Evolution
Chlamydia trachomatis is an obligate intracellular bacterium that causes serious diseases in humans. Rectal infection and disease caused by this pathogen are important yet understudied aspects of C. trachomatis natural history.